Introduction: What is Upadacitinib?
Upadacitinib is a medication classified as a Janus kinase (JAK) inhibitor. It is primarily used to treat autoimmune conditions, where the immune system mistakenly attacks the body?s own tissues. By inhibiting specific enzymes involved in the inflammatory process, Upadacitinib helps reduce symptoms and improve the quality of life for patients suffering from chronic inflammatory diseases.
Uses of Upadacitinib
Upadacitinib has been approved for several medical uses, including: